OVERSEA CHINESE BANKING Corp Ltd Has $731,000 Stock Holdings in The Procter & Gamble Company (NYSE:PG)

OVERSEA CHINESE BANKING Corp Ltd grew its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 41.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,989 shares of the company’s stock after buying an additional 1,471 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Procter & Gamble were worth $731,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Dfpg Investments LLC boosted its holdings in Procter & Gamble by 1.7% in the fourth quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after acquiring an additional 424 shares during the last quarter. Garrett Wealth Advisory Group LLC boosted its holdings in Procter & Gamble by 6.3% in the third quarter. Garrett Wealth Advisory Group LLC now owns 4,419 shares of the company’s stock valued at $645,000 after acquiring an additional 260 shares during the last quarter. N.E.W. Advisory Services LLC boosted its holdings in Procter & Gamble by 14.6% in the third quarter. N.E.W. Advisory Services LLC now owns 94,424 shares of the company’s stock valued at $13,772,000 after acquiring an additional 12,016 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Procter & Gamble by 0.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 16,003,260 shares of the company’s stock valued at $2,298,184,000 after acquiring an additional 131,339 shares during the last quarter. Finally, Miracle Mile Advisors LLC boosted its holdings in Procter & Gamble by 105.5% during the fourth quarter. Miracle Mile Advisors LLC now owns 59,363 shares of the company’s stock worth $8,699,000 after buying an additional 30,473 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the transaction, the chief executive officer now owns 4,859 shares of the company’s stock, valued at approximately $768,256.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the transaction, the chief executive officer now owns 4,859 shares of the company’s stock, valued at approximately $768,256.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Marc S. Pritchard sold 101,704 shares of the business’s stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $153.57, for a total value of $15,618,683.28. Following the transaction, the insider now directly owns 163,428 shares of the company’s stock, valued at approximately $25,097,637.96. The disclosure for this sale can be found here. In the last three months, insiders sold 279,063 shares of company stock worth $43,187,745. 0.17% of the stock is currently owned by company insiders.

Procter & Gamble Stock Performance

PG opened at $158.14 on Monday. The business has a fifty day simple moving average of $159.14 and a 200 day simple moving average of $153.02. The company has a market capitalization of $372.11 billion, a PE ratio of 25.84, a price-to-earnings-growth ratio of 3.19 and a beta of 0.44. The Procter & Gamble Company has a 1 year low of $141.45 and a 1 year high of $163.14. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.69 and a quick ratio of 0.48.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.10. The firm had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a return on equity of 33.77% and a net margin of 18.00%. The company’s revenue was up .6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.37 EPS. Research analysts expect that The Procter & Gamble Company will post 6.53 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.55%. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Wells Fargo & Company raised their target price on Procter & Gamble from $162.00 to $170.00 and gave the stock an “overweight” rating in a report on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft raised their price target on Procter & Gamble from $170.00 to $172.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Stifel Nicolaus raised their price target on Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a research report on Wednesday, January 24th. The Goldman Sachs Group began coverage on Procter & Gamble in a research report on Friday, March 1st. They set a “neutral” rating and a $168.00 price target on the stock. Finally, Raymond James lifted their target price on Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research report on Wednesday, January 24th. Seven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $168.53.

Read Our Latest Stock Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.